EHR

VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025

SAN JOSE, CALIFORNIA / ACCESS Newswire / December 12, 2025 / VSee Health, Inc. (NASDAQ:VSEE) a leader in innovative telemedicine…

1 month ago

Smart Meter and eClinicalWorks More Than Double RPM Adoption in 2025, Powering a New Era of Connected Care for Patients

TAMPA, Fla.--(BUSINESS WIRE)--Smart Meter, the leader in Cellular RPM™ and the nation’s most trusted source of patient-generated vital health data,…

1 month ago

BrainCheck Awarded $500K NIH SBIR Phase I Grant to Advance eConsult Platform for Cognitive Care

AUSTIN, Texas--(BUSINESS WIRE)--#CognitiveHealth--BrainCheck, the leading FDA Class II digital cognitive assessment and care platform, has been awarded a $500,000 SBIR…

1 month ago

VSee Health, Inc. Regains Compliance with Nasdaq Stockholders’ Equity Requirement

SAN JOSE, CALIFORNIA / ACCESS Newswire / December 12, 2025 / VSee Health, Inc. (Nasdaq:VSEE, VSEEW), a leading provider of…

1 month ago

Cadwell and Medical Informatics Corp. Announce Partnership to Bring Neurodiagnostic Data into Clinical Intelligence Ecosystem

KENNEWICK, Wash. and HOUSTON, Dec. 11, 2025 /PRNewswire/ -- Cadwell, a global leader in neurodiagnostic and monitoring solutions, and Medical…

1 month ago

Geneva PE Announces Funding and Launch of NXXIM (Nexus Enterprise Imaging LLC), an AI-Powered Medical Imaging Platform

Geneva PE's funding of NXXIM will create a cutting-edge AI platform that unifies patient data and empowers clinicians to make…

1 month ago

KNOBLOCH Information Group, BEN, and Skye Inteligencia LATAM Form Skye Salud to Modernize Healthcare in Mexico with Sovereign AI

WILMINGTON, Del. and MEXICO CITY, Dec. 11, 2025 /PRNewswire/ -- Brand Engagement Network, Inc. (Nasdaq: BNAI) ("BEN"), a developer of…

1 month ago

Ritten Announces $35M Series B Investment Led by Five Elms Capital

PHILADELPHIA, Dec. 11, 2025 /PRNewswire/ -- Ritten, a leading AI-powered system of record for behavioral health providers, today announced a $35…

1 month ago

AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease

AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease Results show, for…

1 month ago

SkinSight™ AI by ModuleMD: Smarter Skin Analysis, Faster Clinical Decisions

GRAND BLANC, Mich., Dec. 10, 2025 /PRNewswire/ -- ModuleMD, ranked as one of America's fastest-growing companies on the Inc. 5000…

1 month ago